Cervarix cervical cancer vaccine

Cervarix cervical cancer vaccine

M715/0666 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 25.4MB

Downloadable file size: 685.6KB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Cervarix cervical cancer vaccine. Cervarix prevents infection from certain strains of the human papillomavirus (HPV), which are associated with the development of cervical cancer. It is designed to prevent against virus strains 16 and 18 and also offers some protection against virus strains 45 and 31. It contains the adjuvant AS04, which boots the response of the immune system to the vaccine. Cervarix is manufactured by GlaxoSmithKline.

Release details: Model release not required. Property release not required.

Keywords: 16, 18, 31, 45, adjuvant as04, adjuvanted, adsorbed, box, cervarix, cervical cancer, dosage, dose, drug, glaxosmithkline, gsk, healthcare, hpv, hpv vaccine, human papilloma virus, immune system, immunisation, immunology, infection, injection, inoculating, inoculation, intramuscular, jab, medical, medicine, oncology, package, packaging, packet, papillomavirus, pharmaceutic, pharmaceutical, pharmacological, pharmacology, pre-filled syringe, preventative, prevention, recombinant, still life, still-life, strain, strains, syringe, treatment, vaccination, vaccination programme, viral

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.